Reed's (REED) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
25 Mar, 2026Executive summary
Leadership transition with Cyril Wallace stepping down as CEO and Neal Cohane appointed interim CEO and joining the Board; board is searching for a permanent CEO.
Focus on stabilizing operations, improving execution, supporting profitable growth, and expanding distribution and product innovation.
Sequential improvements in net sales, gross margin, and net loss in Q4 2025, reflecting progress in operational performance initiatives.
Expansion into new channels and product launches to drive growth in 2026.
Financial highlights
Q4 2025 net sales were $7.5M, down from $9.7M year-over-year; FY 2025 net sales were $34.1M, down from $38.0M.
Gross profit was $1.5M (20% margin) in Q4 2025 vs. $2.9M (30% margin) in Q4 2024; FY 2025 gross profit was $7.0M (20% margin) vs. $11.4M (30% margin) in FY 2024.
Delivery and handling costs reduced by 35% to $1.1M and per case decreased to $2.46 in Q4 2025 from $3.00 in Q4 2024.
Net loss improved to $3.8M (-$0.44/share) from $4.1M (-$1.33/share) in Q4 2025; FY 2025 net loss was $15.8M vs. $13.2M in FY 2024.
Cash used in operations was $3.8M in Q4 2025; FY 2025 net cash used in operations was $17.0M; cash balance $10.4M and total debt $9.3M as of year-end.
Outlook and guidance
2026 focus on expanding into food service, convenience, and underpenetrated markets, with margin expansion expected through disciplined trade spend, improved pricing, and operational efficiencies.
Strategic initiatives include leveraging in-house sales, outsourced brokers, direct store distribution, and investing in marketing and innovation, especially in Asia.
Recent uplisting to NYSE American expected to enhance market presence and investor engagement.
Latest events from Reed's
- Q2 2024 saw double-digit sales growth, margin gains, and improved but still risky profitability.REED
Q2 20241 Feb 2026 - Net sales and margins dropped, but new funding and restructuring target 2025 recovery.REED
Q3 202414 Jan 2026 - Financial restructuring and product innovation set the stage for strong growth in 2025.REED
The Sidoti Small-Cap Virtual Investor Conference11 Jan 2026 - Gross margin hit 30% as debt fell and new products and capital set up 2025 growth.REED
Q4 202426 Dec 2025 - Five-year warrants with cash/cashless exercise, anti-dilution, and strong investor protections.REED
Registration Filing4 Dec 2025 - IPO offers shares and warrants to fund growth amid ongoing losses and pending NYSE listing.REED
Registration Filing2 Dec 2025 - Registration enables resale of 18.8M shares after major financings and debt conversions.REED
Registration Filing29 Nov 2025 - Registering 5M shares for resale after $5M placement; expanding in health-focused beverages.REED
Registration Filing29 Nov 2025 - 18.8 million shares registered for resale as company targets growth in natural beverages.REED
Registration Filing29 Nov 2025